At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
In Brief
A Phase 2 clinical trial evaluating Resveratrol and Placebo for Metabolic Syndrome X. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The Metabolic Syndrome is a high prevalence disease worldwide. About a quarter of the adult population suffers the disease. Resveratrol is a substance found in many plants, including grapes, nuts and wine, but it's also found in Polygonum cuspidatum. There is evidence that resveratrol consumption has beneficial effects on glucose and lipids metabolism, blood pressure and body weight. The aim of this study was to evaluate the effect of resveratrol on metabolic syndrome, insulin sensitivity and insulin secretion. The investigators hypothesis was that the administration of resveratrol modifies the metabolic syndrome, insulin sensitivity and insulin secretion.
Study Details
Timeline
Interventions
Resveratrol capsules of 500 mg three times per day before meals with a total dosis of 1500 mg per day.
Calcined magnesia capsules, 500 mg, three times per day before meals with a total dose per day of 1500 mg